CCCC - Company ID 0001662579
The table below shows C4 Therapeutics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $74.60M | $55.50M | $126.59M | $29.75M | $76.12M | $181.73M |
| Short-term investments | - | - | - | - | $233.16M | $189.96M |
| Receivables | $2.40M | $3.10M | $11.80M | $1.47M | $5.72M | $4.48M |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $258.11M |
| $257.77M |
| $271.19M |
| $287.56M |
| $325.69M |
| $381.01M |
| Property, plant & equipment | $4.74M | $5.84M | $7.13M | $7.40M | $3.11M | $3.32M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $359.07M | $349.60M | $376.45M | $430.84M | $506.76M | $400.14M |
| Accounts payable | $858.00K | $1.33M | $1.45M | $1.17M | $4.51M | $5.68M |
| Total current liabilities | $33.03M | $45.18M | $42.77M | $44.55M | $51.25M | $43.85M |
| Long-term debt | - | - | $0.00 | $9.20M | $10.77M | $10.05M |
| Total liabilities | $102.49M | $133.62M | $130.34M | $141.61M | $117.16M | $119.35M |
| Retained earnings | -$738.69M | -$633.70M | -$528.38M | -$395.89M | -$267.71M | -$183.82M |
| Total equity | $256.59M | $215.99M | $246.11M | $289.23M | $389.61M | $280.79M |